Journal Abbreviation: Mater. Tech. Rep. Publication Frequency: The publication frequency of Materials Technology Reports is bi-annual. Article Processing Charges (APC):Click here for more details Publishing Model: Open Access Submission to final decision: days Acceptance to publication: days |
About the Journal
Materials Technology Reports (MTR) is a peer-reviewed, open access journal of materials science and engineering. The journal welcomes submissions from worldwide researchers, and practitioners in the field of materials, which can be original research articles, review articles, editorials, case reports, commentaries, etc.Announcements
New Author Guidelines are updated |
|
Please follow the journal's author guideline and the required article template to prepare your manuscript. |
|
Posted: 2023-09-09 | More... |
More Announcements... |
Vol 2, No 1 (2024) |
Table of Contents
Original Research Article
by P. R. Sekhar Reddy
Mater. Tech. Rep.
2024,
2(1);
doi: 10.59400/mtr.v2i1.461
57 Views,
44 PDF Downloads
In this study, Zr-doped HfO2 (HZO) based resistive random-access memory (RRAM) device were fabricated. The Hf:Zr (1:1) ratio in the HZO films were controlled by changing the HfO2 and ZrO2 cycle ratio during the atomic layer deposition (ALD) process. Next, we studied the structural and electrical properties of the Au/HZO/TiN RRAM device structure. The RRAM devices exhibits an excellent resistance ratio of the high resistance state (HRS) to the low resistance state (LRS) of ~103 A, and as well as good endurance (300 cycles) and retention (>103 s), respectively. Further, the device showed different conduction mechanism in LRS and HRS modes. The lower biased linear region is dominated by ohmic conductivity, whereas the higher biased nonlinear region is dominated by a space charge limited current conduction. This device is suitable for application in future high-density nonvolatile memory RRAM devices.
|
Editorial
by Chong Qiu
Mater. Tech. Rep.
2024,
2(1);
doi: 10.59400/mtr.v2i1.460
26 Views,
24 PDF Downloads
Only a few nanomedicines have entered clinical application after over a decade and billions of dollars of investments in nanoscience and nanotechnology around the world. So, what lower the development of nanodrug? Recently, at our recent Editorial and Editorial Advisory Board meeting, we asked ourselves to address these questions and accelerate the development of nano pharmaceuticals. We will work with leaders in the area of drug supply to share our experiences and compare efforts around the world.
|